By Dr Joanne Emily Joseph

Journal articles

Parsi K; Exner T; Low J; Dang Fung Ma D; Joseph JE, 2009, 'In vitro Effects of Detergent Sclerosants on Antithrombotic Mechanisms', European Journal of Vascular and Endovascular Surgery, 38, pp. 220 - 228

Burt R; Collinge J; Kile B; Joseph JE; Milliken ST, 2008, 'Description of a novel mutation leading to MYH9-related disease', Thrombosis Research, 122, pp. 861 - 863

Parsi K; Exner T; Connor DE; Herbert AD; Ma DD; Joseph JE, 2008, 'The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro', European Journal of Vascular and Endovascular Surgery, 36, pp. 216 - 223

Bryant A; Low J; Austin SA; Joseph JE, 2008, 'Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T`s score and particle gel immunoassay', British Journal of Haematology, 143, pp. 721 - 726

Parsi K; Exner T; Connor DE; Ma DD; Joseph JE, 2007, 'In Vitro Effects of Detergent Sclerosants on Coagulation, Platelets and Microparticles', European Journal of Vascular and Endovascular Surgery, 34 (6), pp. 731 - 740

Chung TS; Connor DE; Joseph JE; Emmett L; Mansberg R; Peters MW; Ma DD; Kritharides L, 2007, 'Platelet activation in acute pulmonary embolism', Journal of Thrombosis and Haemostasis, 5, pp. 918 - 924

Chung T; Connor D; Joseph J; Emmett L; Mansberg R; Ma D; Kritharides L, 2007, 'Shedding of P-selectin from Activated Platelets Correlates with the Severity of Right Ventricular Dysfunction During Acute Pulmonary Embolism', Heart, Lung and Circulation, 16, pp. S61 - S61, http://dx.doi.org/10.1016/j.hlc.2007.06.157

Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO, 2006, 'Fibrinogen Darlinghurst: Hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications', Thrombosis and Haemostasis, 96, pp. 685 - 687, http://dx.doi.org/10.1160/TH06-08-0425

Parsi K; Exner T; Connor DE; Joseph JE; Fung D, 2006, 'A convenient source of carbon dioxide for sclerosant foams', Dermatologic Surgery, 32, pp. 1533 - 1534

Joseph JE, 2004, 'Thrombophilia', Australian Doctor, 11, pp. 2 - 7

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'A new activated factor X-based clotting method with improvedspecificity for procoagulant phospholipid', Blood Coagulation and Fibrinolysis: an International Journal in Haemostasis and Thrombosis, 14, pp. 773 - 779

Joseph JE; Courtenay BG; Neil MJ; Mcgrath MA; Ma DD, 2003, 'A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery', Journal of Thrombosis and Haemostasis, pp. 351 - 0351

Connor DE; Joseph JE; Baron D; Muller DW; Roy P; Wilson S; Ma DD, 2003, 'Abciximab therapy post elective coronary artry stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin an dplatelet-monocyte aggregates', Journal of Thrombosis and Haemostasis, pp. 1769 - 1769

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'Detection of procoagulants with a more reliable nonactivated clotting test', Journal of Thrombosis and Haemostasis, pp. 1598 - 1598

Low J; Joseph JE; Shorey N; Mcgrath MA; Javen D, 2003, 'Diagnosis utility of Simplify d-dimer - a new d-dimer test for patients with suspected venous thromboembolism', Journal of Thrombosis and Haemostasis, pp. 1451 - 1451

Low J; Joseph JE; Shorey N; Mcgrath MA; Javen D, 2003, 'Diagnostic utility of Simplify d-dimer- a new d-dimer test for patients with suspected venous thromboembolism', Journal of Thrombosis and Haemostasis, 1, pp. 1451 - 1451

Exner T; Joseph JE; Low J; Connor DE; Ma DD, 2003, 'Procoagulant phospholipid in blood normally associates mainly with cells or aggregates larger than microparticles or platelets', Journal of Thrombosis and Haemostasis, pp. 1078 - 1078

Joseph JE; Harrison P; Mackie IJ; Isenberg DA; Machin SJ, 2001, 'Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis', British Journal of Haematology, 115, pp. 451 - 459, http://dx.doi.org/10.1046/j.1365-2141.2001.03101.x

Harrison P; Robinson MSC; Mackie IJ; Joseph J; McDonald SJ; Liesner R; Savidge GF; Pasi J; Machin SJ, 1999, 'Performance of the platelet function analyser PFA-100® in testing abnormalities of primary haemostasis', Blood Coagulation and Fibrinolysis, 10, pp. 25 - 31, http://dx.doi.org/10.1097/00001721-199901000-00004

Joseph JE; Donohoe S; Harrison P; Mackie IJ; Machin SJ, 1998, 'Platelet activation and turnover in the primary antiphospholipid syndrome', Lupus, 7, pp. 333 - 340, http://dx.doi.org/10.1191/096120398678920163

Joseph JE; Machin SJ, 1997, 'New antiplatelet drugs', Blood Reviews, 11, pp. 178 - 190, http://dx.doi.org/10.1016/S0268-960X(97)90018-7

Joseph J; Booker V; Concannon A, 1995, 'The diagnosis and management of vitamin B12 deficiency', Modern Medicine of Australia, 38, pp. 80 - 89

Joseph J; Pink J; Ribeiro A; Stewart IM, 1994, 'In vitro Characteristics of ‘Undercollected’ Units of Whole Blood in CP2D‐A', Vox Sanguinis, 67, pp. 275 - 279, http://dx.doi.org/10.1111/j.1423-0410.1994.tb01251.x

Joseph J; Pink J; Ribeiro A; Stewart IM, 1994, 'In vitro Characteristics of 'Undercollected' Units of Whole Blood in CP2D-A', Vox Sanguinis, 67, pp. 275 - 279, http://dx.doi.org/10.1159/000462614

Back to profile page